“Innovative therapeutics for autoimmune diseases of the intestinal mucosa have largely been dominated by injectable drugs. Our small molecule, OR-812, has the potential to offer IBD patients a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback